Quick View
| Metric | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue | ¥179.3B | ¥206.1B | −13.0% |
| Operating Income | ¥6.3B | ¥28.4B | −77.8% |
| Profit Before Tax | ¥4.0B | ¥27.4B | −85.3% |
| Net Income | ¥3.3B | ¥19.2B | −82.8% |
| ROE | 0.4% | 2.2% | - |
Executive Summary
FY2026 Q1 recorded Revenue of ¥179.3B (¥-26.8B YoY, -13.0%), Operating Income of ¥6.3B (¥-22.1B YoY, -77.8%), Ordinary Income of ¥3.0B (¥-25.5B YoY, -89.4%), and Net Income of ¥3.3B (¥-15.9B YoY, -82.8%), representing a substantial decline in both revenue and profit. In addition to lower revenue, a decline in gross margin (54.4%, -1.8pt YoY) and an increase in SG&A (¥89.2B, +¥3.2B) worsened operating leverage, pushing the operating margin down sharply to 3.5% (from 13.8%, -10.3pt). An increase in financial expenses to ¥3.0B (prior year ¥2.1B) further widened the decline below ordinary income, compressing the net margin to 1.8% (from 9.3%, -7.5pt). Operating Cash Flow (OCF) improved substantially to ¥22.9B (+106.0% YoY), supported by accounts receivable collections of ¥73.9B, partially offset by an increase in inventories of ¥27.5B and a decrease in accounts payable of ¥31.3B. Free Cash Flow was ¥12.4B and covered capital expenditures of ¥9.2B, but did not cover dividend payments of ¥21.1B. Progress toward Full Year guidance (Revenue ¥1,010.0B, Operating Income ¥194.0B, Net Income ¥125.0B) is significantly behind at 17.8% of Revenue, 3.2% of Operating Income, and 2.6% of Net Income, reflecting a back-loaded order-to-shipment business model.
Drivers of Performance
[Revenue] Revenue was ¥179.3B (-13.0% YoY). As a single-segment company (manufacture and sale of scientific instruments), detailed segment analysis is not available; however, contract liabilities increased to ¥62.0B (from ¥49.6B, +25.0%), suggesting orders are accumulating but conversion to shipments is delayed. Cost of goods sold was ¥81.7B (¥-2.5B), leaving gross profit of ¥97.6B and a gross margin of 54.4% (down from 56.2%, -1.8pt). Changes in product mix, delayed price pass-through, or reduced fixed-cost absorption likely pressured gross margin.
[Profitability] Operating Income fell sharply to ¥6.3B (-77.8% YoY). SG&A increased to ¥89.2B (+¥3.2B, +3.6%), and the SG&A ratio worsened to 49.8% (from 41.7%, +8.1pt), meaning fixed-cost burden weighed heavily amid declining sales. The operating margin deterioration to 3.5% (from 13.8%, -10.3pt) was driven by both gross margin decline and higher SG&A. Financial income was ¥0.7B versus financial expenses of ¥3.0B (up from ¥2.1B, +43.8%), increasing interest burden and driving Profit Before Tax down to ¥4.0B (-85.4% YoY). After income taxes of ¥0.7B (effective tax rate 17.7%), Net Income was ¥3.3B (-82.8% YoY). Other comprehensive income improved, with foreign currency translation adjustments from foreign operations of ¥5.7B and cash flow hedge gains of ¥1.7B, bringing Comprehensive Income to ¥10.7B (from ¥0.5B). No material extraordinary items were noted, indicating limited impact from one-time events. In conclusion, the results reflect a sharp revenue decline due to demand slowdown and shipment timing delays, compounded by higher fixed costs and interest expense.
Key Financial Metrics
[Profitability] Operating margin 3.5% (prior 13.8%), Net margin 1.8% (prior 9.3%)—both down materially. ROE 0.4% (prior 2.2%) decomposes into Net margin 1.8% × Total asset turnover 0.098 × Financial leverage 2.09×, with margin deterioration as the main driver. EBIT margin of 3.5% is diluted by an interest burden factor of 0.64 (Profit Before Tax ¥4.0B ÷ Operating Income ¥6.3B), and interest coverage on an operating income basis is about 2.1× (¥6.3B ÷ financial expenses ¥3.0B), a low level. [Cash Quality] OCF ¥22.9B is 6.98× Net Income ¥3.3B, indicating high cash quality. The large accounts receivable collection (+¥73.9B) was the primary driver, though inventory increase (-¥27.5B) and accounts payable decrease (-¥31.3B) pressured working capital. [Investment Efficiency] Total assets ¥1,824.7B and Net assets ¥874.3B yield total asset turnover of 0.098x (annualized 0.39x), a low level. Goodwill of ¥518.6B represents 28.4% of total assets and 59.3% of net assets, making impairment sensitivity high. [Financial Soundness] Equity Ratio 47.9% (prior 47.7%) remains stable. Interest-bearing debt totaled ¥579.0B (short-term borrowings ¥87.2B + long-term borrowings ¥491.8B), net debt ¥322.1B, net D/E 0.37x. Current ratio 2.28x (current assets ¥732.4B ÷ current liabilities ¥321.0B) indicates solid short-term liquidity.
Cash Flow Analysis
OCF improved substantially to ¥22.9B (from ¥11.1B, +106.0%). Profit Before Tax ¥4.0B plus depreciation & amortization ¥14.0B produced a subtotal before working capital changes of ¥47.1B. Large accounts receivable collections (+¥73.9B) were the biggest contributor, but inventory increases of ¥27.5B and a decrease in accounts payable of ¥31.3B absorbed cash; an increase in contract liabilities of ¥10.5B partially offset these outflows. After corporate tax payments of ¥17.3B and interest payments of ¥6.4B, OCF was ¥22.9B. Investing cash flow was -¥10.5B, mainly capital expenditures ¥9.2B and intangible asset investment ¥1.1B. Free Cash Flow was ¥12.4B (OCF ¥22.9B + Investing CF -¥10.5B), covering roughly 0.59× of dividend payments ¥21.1B, which was insufficient, but a robust cash balance of ¥256.9B provided buffer. Financing cash flow was -¥0.4B: borrowings included short-term borrowings ¥30.0B and long-term borrowings ¥33.4B, against repayments of short-term borrowings ¥20.0B, long-term borrowings ¥20.0B, dividend payments ¥21.1B, and lease repayments ¥3.6B. Cash and cash equivalents increased by ¥14.2B, including a ¥2.2B forex effect, ending the period at ¥256.9B. In working capital, while accounts receivable collections advanced, inventory buildup and accounts payable compression continued; normalizing inventory turnover will be key to sustaining OCF in subsequent periods.
Quality of Earnings
Ordinary Income was ¥3.0B while Net Income was ¥3.3B, with an effective tax rate of 17.7%, relatively low; no extraordinary items were noted, supporting a view of recurring earnings. On the non-operating side, financial income was ¥0.7B versus financial expenses of ¥3.0B, and other income of ¥0.1B versus other expenses of ¥2.2B, both weighing on ordinary income. The fact that OCF ¥22.9B substantially exceeds Net Income ¥3.3B is positive for earnings quality; accruals are negative, indicating conservative profit recognition. Comprehensive Income ¥10.7B significantly exceeded Net Income ¥3.3B, driven by Other Comprehensive Income ¥7.4B (foreign currency translation adjustments from foreign operations ¥5.7B, cash flow hedge ¥1.7B), reflecting significant FX impact and a high overseas revenue ratio. Working capital movements, notably the large accounts receivable collection, boosted OCF, indicating that actual cash-generating ability is stronger than net income suggests.
Forecasts & Guidance
Full Year guidance calls for Revenue ¥1,010.0B (+16.1% YoY), Operating Income ¥194.0B (+16.1% YoY), and Net Income ¥125.0B (+9.6% YoY). Q1 progress rates versus full year are 17.8% of Revenue (standard 25% benchmark -7.2pt), 3.2% of Operating Income (-21.8pt), and 2.6% of Net Income (-22.4pt), indicating significant lag. Given contract liabilities of ¥62.0B, orders are secured but shipments are expected to concentrate in the second half. Achieving full year targets requires substantial shipment acceleration from Q2 onward, recovery in gross margin, and restraint in SG&A. Dividend forecast is ¥9.5 per share (virtually flat from ¥9.4 this period), implying an expected payout ratio of roughly 17%, a sustainable level. No revisions to forecasts have been made; the company expects to make up ground in the second half.
Shareholder Returns
Dividend payments for the period totaled ¥21.1B, equivalent to ¥9.4 per share. The apparent high dividend payout ratio versus Q1 Net Income of ¥3.3B is largely a timing mismatch between dividend payments and quarterly earnings. Based on Full Year Net Income guidance ¥125.0B, the annual dividend forecast of ¥9.5 per share (approx. total ¥21.5B) implies a payout ratio of about 17%, an appropriate level. Free Cash Flow ¥12.4B did not fully cover dividend payments of ¥21.1B, but ample cash on hand of ¥256.9B and expected OCF improvement over the year support dividend sustainability. Treasury stock equivalent of ¥403.0B was cancelled leaving a balance of ¥0.04B, aimed at improving capital efficiency. No share buyback was announced; shareholder returns are dividend-focused.
Risk Factors
-
Goodwill impairment risk: Goodwill of ¥518.6B represents 59.3% of Net Assets ¥874.3B; under IFRS goodwill is not amortized, increasing sensitivity to impairment. A final market demand slowdown or delayed integration synergies could trigger significant impairment charges.
-
Rising interest burden risk: Financial expenses increased to ¥3.0B (¥+0.9B YoY, +43.8%), and interest coverage is about 2.1×, a low level. Of interest-bearing debt ¥579.0B, short-term borrowings ¥87.2B increased YoY by 27.3%, posing refinancing cost and profit pressure risks in a rising rate environment.
-
Working capital management risk: Inventories increased to ¥237.8B (¥+27.5B YoY) while accounts payable decreased to ¥86.0B (¥-31.0B YoY), resulting in working capital absorbing cash. Inventory obsolescence, impairment, or deteriorating supply chain management could materialize into cash flow deterioration and reduced profitability.
Industry Benchmark (Reference, Company Compilation)
Profitability & Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.5% | 6.8% (2.9%–9.0%) | −3.3pt |
| Net Margin | 1.8% | 5.9% (3.3%–7.7%) | −4.1pt |
The company's profitability lags the industry median, ranking in the lower tier for both operating and net margins.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | −13.0% | 13.2% (2.5%–28.5%) | −26.2pt |
Revenue growth is well below the industry median and diverges from the broader manufacturing growth trend.
※ Source: Company compilation based on public financial statements
Key Points from the Results
-
Deterioration in gross margin to 54.4% (-1.8pt YoY) and SG&A ratio to 49.8% (+8.1pt YoY) has compressed operating margin to 3.5%; recovery in gross margin (through price pass-through and product mix improvement) and SG&A restraint in the second half are essential to meet full year targets. The buildup of contract liabilities ¥62.0B indicates secured orders, but shipment conversion speed and profitability are the focus.
-
The divergence between OCF ¥22.9B and Net Income ¥3.3B (CF/NI = 6.98×) indicates high earnings quality, but excluding the temporary boost from accounts receivable collection ¥73.9B, inventory increases ¥27.5B and accounts payable decreases ¥31.3B show continued working capital cash absorption. Normalization of inventory turnover and supply chain improvements are key to sustaining cash flow in subsequent periods.
-
The combination of goodwill ¥518.6B (59.3% of net assets) and interest coverage of about 2.1× suggests financial vulnerability in a deteriorating macro environment. Given the upward trend in interest burden ¥3.0B (+43.8% YoY) and the back-loaded performance plan, monitoring shipment progress and gross margin trends from Q2 onward is critical.
This report was automatically generated by AI analyzing XBRL financial disclosure data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are compiled by the Company from public financial statements for reference. Investment decisions are your responsibility; please consult a professional advisor as necessary.
AI Financial Analysis
Executive Summary
FY2026 Q1 was a weak start, with sharply lower revenue and a disproportionate collapse in operating and net profit. Revenue declined 13.0% year on year to ¥17.93bn. Operating income fell 77.8% to ¥0.63bn, while net income declined 82.8% to ¥0.33bn. The gross margin contracted 180bp year on year to 54.4% from 56.2%. The operating margin compressed 1,024bp to 3.5% from 13.8%, reflecting both weaker volume and a failure to reduce the cost base in line with sales. SG&A expenses increased 3.7% to ¥8.92bn despite the revenue decline, lifting the SG&A-to-revenue ratio by approximately 802bp to 49.8%. Net margin contracted 747bp to 1.8% from 9.3%. Finance costs increased 44.7% to ¥0.30bn, further reducing earnings conversion below the operating line. The interest burden was 0.638, meaning finance costs absorbed roughly 36% of EBIT, and EBIT interest coverage was only 2.1x. Operating cash flow nevertheless increased to ¥2.30bn from ¥1.11bn, substantially exceeding net income of ¥0.33bn. This cash conversion was driven chiefly by a ¥7.40bn reduction in receivables, partly offset by a ¥2.75bn inventory build and a ¥3.13bn decline in payables. Free cash flow was positive at ¥1.24bn after ¥0.92bn of capital expenditure. Balance-sheet liquidity remains adequate, with a calculated current ratio of 2.28x, cash of ¥25.69bn, and a 47.9% equity ratio. However, goodwill of ¥51.86bn equals 59.3% of equity, leaving the capital base meaningfully exposed to the retention of acquired-business values. Full-year guidance requires a substantial acceleration: Q1 represented 17.8% of revenue guidance, 3.2% of operating-income guidance, and 2.6% of net-income guidance. The investment debate therefore centers on whether the Q1 sales and margin weakness is temporary enough for the company to restore its guided 19.2% full-year operating margin.
Profitability Analysis
Annualized DuPont ROE was 1.5%, comprising a 1.8% net profit margin, 0.393x annualized asset turnover, and 2.09x financial leverage. The largest adverse driver was margin compression rather than leverage: the net margin fell to 1.8%, while annualized asset turnover remained modest and financial leverage remained above 2x. Gross profit fell 15.8% to ¥9.76bn, faster than the 13.0% revenue decline, producing the 180bp gross-margin contraction. Operating income fell much faster than gross profit because SG&A rose to ¥8.92bn from ¥8.60bn; this unfavorable operating leverage drove operating margin down to 3.5%. SG&A exceeded revenue by 62.2 percentage points in growth-rate terms, signaling limited near-term cost flexibility. The low operating-efficiency alert is warranted: a 3.5% EBIT margin is below the 5% concern threshold and far below the 19.2% margin embedded in full-year guidance. The tax burden of 0.818 was normal, with an effective tax rate of 18.2%, so tax was not the principal cause of profit weakness. Conversely, the high-interest-burden alert is material: the 0.638 interest burden and 2.1x EBIT-to-finance-cost coverage show that debt servicing meaningfully reduces already-compressed operating profit. IFRS avoids routine goodwill amortization, so reported operating profit is not reduced by the JGAAP-style goodwill amortization that would complicate comparison with some Japanese peers; the central acquisition-accounting risk is instead future impairment. Annualized ROIC of 1.4% is also weak, indicating that the current quarterly earnings run-rate is generating returns well below a normal cost-of-capital threshold. A sustained recovery requires both renewed revenue growth and a meaningful reduction in SG&A intensity.
Growth Assessment
Q1 revenue of ¥17.93bn was 13.0% below the prior-year quarter, and the single reported business is the manufacture and sale of scientific instruments. The gross-margin decline indicates that the revenue shortfall was not fully absorbed through variable costs. The more severe operating-income decline of 77.8% demonstrates high fixed-cost exposure in the current revenue environment. Receivables declined 25.6% year on year to ¥21.17bn, which supported Q1 cash flow but does not itself establish an improvement in underlying demand. Inventories increased 13.9% from the ¥20.88bn reported at FY2025 year-end to ¥23.79bn, requiring attention alongside the sales contraction. Annualized DSO of 108 days, DIO of 266 days, and a 277-day cash conversion cycle are all high for manufacturing benchmarks. These metrics may reflect the long production and sales cycle of analytical and scientific instrumentation, but they also increase exposure to order timing, delayed customer acceptance, and inventory obsolescence. Full-year guidance calls for revenue of ¥101.0bn, operating income of ¥19.4bn, and net income of ¥12.5bn. Q1 revenue progress of 17.8% is 7.2 percentage points below the standard 25% quarterly pace, while operating-income and net-income progress are respectively 21.8 and 22.4 percentage points below pace. The operating-income and net-income gaps exceed the 10-percentage-point threshold and imply that management expects a strongly back-end-loaded earnings profile. Full-year guidance was not revised, so subsequent quarters need to demonstrate a pronounced sales recovery and operating leverage.
Financial Health
Liquidity is sound on reported balance-sheet amounts. Current assets of ¥73.24bn exceeded current liabilities of ¥32.10bn, resulting in calculated working capital of ¥41.13bn and a current ratio of 2.28x. The quick ratio was approximately 1.46x based on cash and trade receivables, which is also above 1.0x. Cash and cash equivalents of ¥25.69bn covered short-term loans of ¥8.72bn by 2.94x. Accordingly, the liquidity-stress alert based on a cash-to-short-term-debt ratio below 0.5x is not supported by the reported cash and short-term-loan balances; near-term refinancing pressure appears limited. Short-term loans increased ¥1.87bn from FY2025 year-end and 27.3% year on year, while long-term loans were ¥49.18bn. Interest-bearing debt was ¥57.90bn, equivalent to a manageable 1.09x debt-to-equity ratio and 39.8% debt-to-capital ratio. Neither the current ratio nor D/E reaches the stated warning thresholds of below 1.0x and above 2.0x, respectively. The maturity profile is favorable relative to current assets, since short-term loans comprise only 15.1% of interest-bearing debt and current assets materially exceed current liabilities. Lease liabilities totalled ¥6.44bn, comprising ¥1.41bn current and ¥5.04bn non-current obligations, and should be included in assessing fixed financial commitments. The principal balance-sheet concern is not immediate liquidity but asset quality: goodwill represents 28.4% of assets and 59.3% of equity. The goodwill-risk alert is therefore justified; any impairment would directly reduce equity and could weaken leverage metrics. Accounts payable declined 26.5% year on year to ¥8.60bn, while trade receivables declined 25.6% to ¥21.17bn. The ¥4.03bn cancellation of treasury stock largely reclassified equity accounts and does not represent a cash improvement in capital resources.
Notable B/S Changes
Treasury stock: +¥4.03bn year on year to approximately nil — cancellation of treasury shares reclassified equity accounts and reduced treasury-share deductions rather than generating operating cash. Short-term loans: +¥1.87bn (+27.3% YoY) to ¥8.72bn — short-term funding increased, although cash of ¥25.69bn still covered this balance by 2.94x. Accounts payable: -¥3.10bn (-26.5% YoY) to ¥8.60bn — lower supplier financing consumed operating cash and may reduce working-capital flexibility. Accounts receivable: -¥7.27bn (-25.6% YoY) to ¥21.17bn — supported Q1 operating cash flow; the sustainability of this collection-driven cash inflow is important. Inventories: +¥2.91bn from FY2025 year-end to ¥23.79bn — the build coincided with lower Q1 revenue and requires monitoring given annualized DIO of 266 days. Goodwill: ¥51.86bn, or 28.4% of assets and 59.3% of equity — stable in absolute terms but remains a large asset concentration with material impairment sensitivity.
Cash Flow Quality
Operating cash flow was ¥2.30bn, equal to 6.98x net income of ¥0.33bn, and the negative 1.1% accruals ratio is favorable on a mechanical earnings-quality measure. OCF therefore does not trail net income; the standard OCF/net-income warning threshold of 0.8x is not breached. However, the high conversion should not be treated as entirely recurring because it was driven mainly by a ¥7.40bn receivables reduction. This inflow was offset materially by a ¥2.75bn inventory increase and a ¥3.13bn reduction in payables, both of which consumed cash. Contract liabilities increased ¥1.05bn, providing an additional source of operating cash. The combination of inventory investment and declining supplier financing means working-capital cash generation may normalize lower if receivable collections do not recur. Cash interest paid rose to ¥0.64bn from ¥0.38bn, consistent with the higher finance-cost burden. Capital expenditure was ¥0.92bn, or 5.1% of Q1 revenue, within a normal manufacturing range. Free cash flow was positive at ¥1.24bn after capital expenditure and supports ordinary investment needs in the quarter. Nevertheless, Q1 dividends paid of ¥2.11bn exceeded Q1 free cash flow by ¥0.87bn, so cash dividend coverage was only 0.59x for the quarter. Cash increased ¥1.42bn overall, ending at ¥25.69bn, aided by operating cash generation and modest net borrowing. The high DSO, DIO, and cash-conversion-cycle alerts are material because they leave cash flow sensitive to collections, production scheduling, and inventory turnover.
Dividend Sustainability
The full-year dividend forecast is ¥19.00 per share against forecast EPS of ¥55.27, implying a forecast dividend payout ratio of approximately 34.4%. This prospective payout ratio is below the 60% sustainability benchmark and appears reasonable if full-year earnings guidance is achieved. Q1 dividend payments were ¥2.11bn, compared with Q1 net income of ¥0.33bn and free cash flow of ¥1.24bn. Quarterly cash coverage was therefore weak, but the payment timing should be assessed against full-year earnings and cash generation rather than Q1 profit alone. Cash of ¥25.69bn and a calculated current ratio of 2.28x provide a buffer for the current distribution. The greater constraint on dividend durability is the wide gap between Q1 earnings and the full-year forecast, together with elevated goodwill and low annualized ROIC. No dividend revision was announced. Dividend sustainability is thus supported by the forecast payout ratio and liquidity, but depends on a substantial recovery in profitability and more normalized working-capital cash conversion through the remainder of FY2026.
Risk Assessment
Business risks include Demand and order-timing risk in scientific instruments: Q1 revenue fell 13.0%, while the unchanged full-year plan requires significant subsequent-quarter acceleration., Operating-leverage risk: SG&A increased 3.7% despite declining revenue, causing operating margin to compress to 3.5% from 13.8%., Working-capital and production-cycle risk: annualized DSO of 108 days, DIO of 266 days, and a 277-day cash conversion cycle increase exposure to delayed collections, customer acceptance timing, and inventory obsolescence., Manufacturing-specific inventory risk: inventories rose ¥2.91bn from FY2025 year-end while quarterly sales declined, potentially increasing exposure to component, configuration, or technology-cycle obsolescence., Foreign-currency risk: exchange differences and cash-flow hedges contributed ¥0.74bn of positive OCI in Q1, indicating that currency movements can materially affect equity and comprehensive income..
Financial risks include Interest burden risk: finance costs of ¥0.30bn consumed about 36% of EBIT, resulting in a 0.638 interest burden and only 2.1x EBIT interest coverage., Goodwill impairment risk: goodwill of ¥51.86bn is 59.3% of equity and 28.4% of total assets; an impairment would reduce equity and worsen leverage ratios., Cash-flow normalization risk: OCF of ¥2.30bn was heavily supported by a ¥7.40bn receivables release, while inventory growth and lower payables consumed ¥5.88bn in aggregate., Capital-return coverage risk: Q1 dividends paid exceeded Q1 free cash flow, requiring either later-period earnings recovery or use of balance-sheet liquidity..
Key concerns include Highest priority: whether revenue and operating margin recover sufficiently to achieve full-year operating-income guidance, given Q1 progress of only 3.2%., High priority: whether high inventory days and the inventory build convert into revenue and cash rather than becoming a source of write-down risk., High priority: whether the company can improve interest coverage through earnings recovery, given the current 2.1x level., Medium-to-high priority: preservation of acquired-business value supporting the ¥51.86bn goodwill balance., The liquidity-stress quality alert should be monitored, but reported cash of ¥25.69bn covers ¥8.72bn of short-term loans by 2.94x, so immediate liquidity stress is not evident from the reported balances..
Investment Implications
Key takeaways include Q1 profitability weakened materially: revenue fell 13.0%, operating income fell 77.8%, and operating margin compressed to 3.5%., Gross-margin compression and SG&A deleveraging were the central causes of the earnings decline., Operating cash flow and free cash flow remained positive, but cash generation was materially assisted by receivables collection and should not be extrapolated without considering inventory and payable movements., Balance-sheet liquidity is adequate, with a 2.28x current ratio, 2.94x cash-to-short-term-loans coverage, and a 47.9% equity ratio., Goodwill concentration is the major structural balance-sheet risk, at 59.3% of equity., The unchanged FY2026 outlook requires a large back-end recovery in operating profit and net income..
Metrics to watch include Quarterly revenue growth and order conversion relative to the ¥101.0bn full-year revenue forecast., Operating margin recovery toward the 19.2% full-year guidance implication and SG&A-to-revenue ratio normalization from 49.8%., Finance costs, EBIT interest coverage, and the interest burden., Receivable days, inventory days, inventory balance, and cash conversion cycle., Operating cash flow excluding the effect of receivables collection., Goodwill relative to equity and any impairment indicators., Free-cash-flow coverage of dividends and delivery of the ¥19.00 per-share dividend forecast..
Regarding relative positioning, The company combines a healthy near-term liquidity profile with weak Q1 operating efficiency, low annualized ROIC of 1.4%, and elevated M&A-related asset concentration. Its IFRS reporting avoids recurring goodwill amortization, which supports comparability of operating profit, but makes impairment discipline on the large goodwill balance particularly important. Relative performance will depend principally on the speed of margin recovery and working-capital normalization rather than on balance-sheet liquidity alone.